Mucinex Nightshift Cold And Flu Tablet, Coated
NDC Package 72854-233-20
Package Information
Mucinex Nightshift Cold And Flu (acetaminophen, dextromethorphan hydrobromide, and triprolidine hydrochloride) tablets is do not take more than directed (see Overdose warning)do not take more than 8 caplets in any 24-hour periodadults and children 12 years of age and over: take 2 caplets every 4 hourschildren under 12 years of age: do not use. This formulation utilizes a tablet, coated delivery system. Marketed by Reckitt Benckiser Llc, this product is identified by NDC 72854-233 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2549034 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG Oral Tablet
- RxCUI: 2549034 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / triprolidine hydrochloride 1.25 MG Oral Tablet
- RxCUI: 2549034 - APAP 325 MG / dextromethorphan hydrobromide 10 MG / triprolidine hydrochloride 1.25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72854 - Reckitt Benckiser Llc
- 72854-233 - Mucinex Nightshift Cold And Flu
- 72854-233-20 - 2 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK
- 72854-233 - Mucinex Nightshift Cold And Flu
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72854-233-20 identifies a specific commercial package of 2 blister pack in 1 carton / 10 tablet, coated in 1 blister pack of Mucinex Nightshift Cold And Flu Maximum Strength, a human over the counter drug labeled by Reckitt Benckiser Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This tablet, coated is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; triprolidine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reckitt Benckiser Llc on July 01, 2021. The current certification is valid through December 31, 2027.
How is this Reckitt Benckiser Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72854023320. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.